A Study of TAK-755 in Adults With Acute Ischemic Stroke

Abroad (travel likely)RecruitingPHASE2

Conditions

Acute Ischemic Stroke

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Honor Health, Scottsdale, Arizona, United States
Contact: Study coordinator (Site Contact) · ashutosh.jadhav@barrowbrainandspine.com · 602-258-2863
Contact: Principal Investigator (Ashutosh Jadhav)

Study leads

Study Director
Takeda

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke

Acute Ischemic Stroke

Abroad (travel likely)RecruitingPHASE2

Beijing, China · Shenzhen, China

Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users

Acute Ischemic Stroke

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China

Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window.

Acute Ischemic Stroke

Abroad (travel likely)RecruitingPHASE3

Puyang, China

Efficacy and Safety of Human Urinary Kallidinogenase Combined With Endovascular Therapy in Acute Ischemic Stroke With Large Vessel Occlusion

Acute Ischemic Stroke

Abroad (travel likely)Recruiting

Shanghai, China